Cargando…

Selective venous sampling catheterisation for localisation of persisting medullary thyroid carcinoma.

Selective venous sampling catheterisation was performed in 19 patients with medullary thyroid carcinoma without known distant metastases for persistent hypercalcitoninaemia after surgery. Calcitonin (CT) gradients were found in the neck and/or the mediastinum in 18 patients and in five patients at d...

Descripción completa

Detalles Bibliográficos
Autores principales: Abdelmoumene, N., Schlumberger, M., Gardet, P., Roche, A., Travagli, J. P., Francese, C., Parmentier, C.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1994
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1969435/
https://www.ncbi.nlm.nih.gov/pubmed/8198983
_version_ 1782134850549972992
author Abdelmoumene, N.
Schlumberger, M.
Gardet, P.
Roche, A.
Travagli, J. P.
Francese, C.
Parmentier, C.
author_facet Abdelmoumene, N.
Schlumberger, M.
Gardet, P.
Roche, A.
Travagli, J. P.
Francese, C.
Parmentier, C.
author_sort Abdelmoumene, N.
collection PubMed
description Selective venous sampling catheterisation was performed in 19 patients with medullary thyroid carcinoma without known distant metastases for persistent hypercalcitoninaemia after surgery. Calcitonin (CT) gradients were found in the neck and/or the mediastinum in 18 patients and in five patients at distant sites also. After venous catheterisation, 13 patients were subjected to repeat surgery. Neck and/or mediastinal tumour foci were found in 12 patients at the sites of the CT gradients. Of these, nine patients had only cervicomediastinal CT gradients: after reoperation, the serum CT level normalised in one, significantly decreased in five, and did not change in three, and no neck relapse occurred after a mean follow-up of 5.3 years. Distant metastases emerged clinically in all five patients with distant gradients and in only one of the 14 patients with no distant gradient. In conclusion, selective venous catheterisation is the most sensitive tool for the localisation of residual disease and for the early detection of distant metastases. However, in patients with only local disease, biochemical cure is rarely obtained after reoperation.
format Text
id pubmed-1969435
institution National Center for Biotechnology Information
language English
publishDate 1994
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-19694352009-09-10 Selective venous sampling catheterisation for localisation of persisting medullary thyroid carcinoma. Abdelmoumene, N. Schlumberger, M. Gardet, P. Roche, A. Travagli, J. P. Francese, C. Parmentier, C. Br J Cancer Research Article Selective venous sampling catheterisation was performed in 19 patients with medullary thyroid carcinoma without known distant metastases for persistent hypercalcitoninaemia after surgery. Calcitonin (CT) gradients were found in the neck and/or the mediastinum in 18 patients and in five patients at distant sites also. After venous catheterisation, 13 patients were subjected to repeat surgery. Neck and/or mediastinal tumour foci were found in 12 patients at the sites of the CT gradients. Of these, nine patients had only cervicomediastinal CT gradients: after reoperation, the serum CT level normalised in one, significantly decreased in five, and did not change in three, and no neck relapse occurred after a mean follow-up of 5.3 years. Distant metastases emerged clinically in all five patients with distant gradients and in only one of the 14 patients with no distant gradient. In conclusion, selective venous catheterisation is the most sensitive tool for the localisation of residual disease and for the early detection of distant metastases. However, in patients with only local disease, biochemical cure is rarely obtained after reoperation. Nature Publishing Group 1994-06 /pmc/articles/PMC1969435/ /pubmed/8198983 Text en https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/.
spellingShingle Research Article
Abdelmoumene, N.
Schlumberger, M.
Gardet, P.
Roche, A.
Travagli, J. P.
Francese, C.
Parmentier, C.
Selective venous sampling catheterisation for localisation of persisting medullary thyroid carcinoma.
title Selective venous sampling catheterisation for localisation of persisting medullary thyroid carcinoma.
title_full Selective venous sampling catheterisation for localisation of persisting medullary thyroid carcinoma.
title_fullStr Selective venous sampling catheterisation for localisation of persisting medullary thyroid carcinoma.
title_full_unstemmed Selective venous sampling catheterisation for localisation of persisting medullary thyroid carcinoma.
title_short Selective venous sampling catheterisation for localisation of persisting medullary thyroid carcinoma.
title_sort selective venous sampling catheterisation for localisation of persisting medullary thyroid carcinoma.
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1969435/
https://www.ncbi.nlm.nih.gov/pubmed/8198983
work_keys_str_mv AT abdelmoumenen selectivevenoussamplingcatheterisationforlocalisationofpersistingmedullarythyroidcarcinoma
AT schlumbergerm selectivevenoussamplingcatheterisationforlocalisationofpersistingmedullarythyroidcarcinoma
AT gardetp selectivevenoussamplingcatheterisationforlocalisationofpersistingmedullarythyroidcarcinoma
AT rochea selectivevenoussamplingcatheterisationforlocalisationofpersistingmedullarythyroidcarcinoma
AT travaglijp selectivevenoussamplingcatheterisationforlocalisationofpersistingmedullarythyroidcarcinoma
AT francesec selectivevenoussamplingcatheterisationforlocalisationofpersistingmedullarythyroidcarcinoma
AT parmentierc selectivevenoussamplingcatheterisationforlocalisationofpersistingmedullarythyroidcarcinoma